Decentralizing clinical trials has quickly gone from luxury to necessity in order to reduce clinical trial times and improve participant engagement. The COVID-19 pandemic has highlighted the critical need to have better, faster access to new drugs, meaning clinical trials can no longer afford to use an inefficient, paper-based approach. According to the US National Library of Medicine’s ClincialTrials.gov site, there are over 55,000 clinical trials actively enrolling participants worldwide right now, so the opportunity to decentralize is great.
Watch this informative on-demand webinar to learn how CROs and pharmaceutical companies can fast track plans for decentralized clinical trials with the Internet of Things (IoT). With IoT-enabled clinical trials, participants are no longer required to appear in-person for clinic visits, and important clinical data can be gathered remotely. While this sounds very efficient, over 76% of all IoT projects fail, resulting in unexpected delays and the lost revenue.
In this on-demand webinar, our presenters will explore the more important requirements for decentralized clinical trials and share the common pitfalls and how to avoid them. From supply chain management and hardware procurement to provisioning and device certification, discover how to make a decentralized clinical trial successful.Watch the on-demand webinar “Demystifying Decentralized Clinical Trials and Enabling Your Study for Success” to learn how to: